GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Equity-to-Asset

SQI Diagnostics (FRA:XSQ) Equity-to-Asset : -3.71 (As of Mar. 2023)


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SQI Diagnostics's Total Stockholders Equity for the quarter that ended in Mar. 2023 was €-9.95 Mil. SQI Diagnostics's Total Assets for the quarter that ended in Mar. 2023 was €2.68 Mil. Therefore, SQI Diagnostics's Equity to Asset Ratio for the quarter that ended in Mar. 2023 was -3.71.

The historical rank and industry rank for SQI Diagnostics's Equity-to-Asset or its related term are showing as below:

FRA:XSQ's Equity-to-Asset is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.59
* Ranked among companies with meaningful Equity-to-Asset only.

SQI Diagnostics Equity-to-Asset Historical Data

The historical data trend for SQI Diagnostics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Equity-to-Asset Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.24 0.21 0.17 -1.05

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 -0.10 -1.05 -1.47 -3.71

Competitive Comparison of SQI Diagnostics's Equity-to-Asset

For the Diagnostics & Research subindustry, SQI Diagnostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQI Diagnostics's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Equity-to-Asset falls into.



SQI Diagnostics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

SQI Diagnostics's Equity to Asset Ratio for the fiscal year that ended in Sep. 2022 is calculated as

Equity to Asset (A: Sep. 2022 )=Total Stockholders Equity/Total Assets
=-7.429/7.053
=-1.05

SQI Diagnostics's Equity to Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

Equity to Asset (Q: Mar. 2023 )=Total Stockholders Equity/Total Assets
=-9.951/2.679
=-3.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SQI Diagnostics  (FRA:XSQ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


SQI Diagnostics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (FRA:XSQ) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines